Name | Number of supported studies | Average coverage | |
---|---|---|---|
squamous epithelial cell | 3 studies | 30% ± 7% |
Insufficient scRNA-seq data for expression of KLK7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 36% | 2798.56 | 525 / 1445 | 65% | 74.75 | 119 / 183 |
ovary | 0% | 0 | 0 / 180 | 97% | 403.86 | 419 / 430 |
skin | 73% | 11346.14 | 1320 / 1809 | 10% | 14.02 | 45 / 472 |
kidney | 70% | 892.64 | 62 / 89 | 0% | 0.17 | 3 / 901 |
pancreas | 0% | 0 | 0 / 328 | 63% | 81.17 | 113 / 178 |
thymus | 0% | 0 | 0 / 653 | 54% | 52.47 | 325 / 605 |
breast | 33% | 443.35 | 152 / 459 | 19% | 16.42 | 212 / 1118 |
brain | 29% | 430.53 | 774 / 2642 | 4% | 0.86 | 29 / 705 |
tonsil | 0% | 0 | 0 / 0 | 31% | 31.73 | 14 / 45 |
uterus | 4% | 79.46 | 6 / 170 | 26% | 19.75 | 120 / 459 |
lung | 2% | 15.62 | 9 / 578 | 21% | 13.78 | 242 / 1155 |
intestine | 0% | 0 | 0 / 966 | 22% | 16.23 | 116 / 527 |
stomach | 1% | 2.89 | 2 / 359 | 20% | 11.45 | 58 / 286 |
adipose | 21% | 275.35 | 247 / 1204 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 15% | 10.39 | 74 / 504 |
liver | 0% | 2.08 | 1 / 226 | 0% | 0.10 | 2 / 406 |
adrenal gland | 0% | 3.18 | 1 / 258 | 0% | 0.05 | 1 / 230 |
prostate | 1% | 4.22 | 2 / 245 | 0% | 0 | 0 / 502 |
blood vessel | 0% | 11.34 | 4 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.64 | 2 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.65 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002803 | Biological process | positive regulation of antibacterial peptide production |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0008544 | Biological process | epidermis development |
GO_0006508 | Biological process | proteolysis |
GO_0001533 | Cellular component | cornified envelope |
GO_0005615 | Cellular component | extracellular space |
GO_0030141 | Cellular component | secretory granule |
GO_0005576 | Cellular component | extracellular region |
GO_0097209 | Cellular component | epidermal lamellar body |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | KLK7 |
Protein name | Kallikrein 7 splice variant 3 (Kallikrein related peptidase 7) Kallikrein-7 isoform 4 Kallikrein-7 isoform 5 Kallikrein related peptidase 7 Kallikrein 7 Kallikrein-7 (hK7) (EC 3.4.21.117) (Serine protease 6) (Stratum corneum chymotryptic enzyme) (hSCCE) |
Synonyms | PRSS6 SCCE hK7 |
Description | FUNCTION: May catalyze the degradation of intercellular cohesive structures in the cornified layer of the skin in the continuous shedding of cells from the skin surface. Specific for amino acid residues with aromatic side chains in the P1 position. Cleaves insulin A chain at '14-Tyr-|-Gln-15' and insulin B chain at '6-Leu-|-Cys-7', '16-Tyr-|-Leu-17', '25-Phe-|-Tyr-26' and '26-Tyr-|-Thr-27'. Could play a role in the activation of precursors to inflammatory cytokines. . |
Accessions | X2J4X7 ENST00000597707.5 [P49862-2] A0A2H4GDB6 ENST00000595820.6 [P49862-1] M0QYU8 Q6DTY1 ENST00000391807.5 [P49862-1] X2J289 ENST00000304045.6 P49862 ENST00000593904.1 A0A2H4GDB2 |